Covered recipient · General Payments record
ALICIA CALOS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,274.71
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $615.31 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $162.72 | 3 |
| ABIOMED | $160.40 | 2 |
| Amgen Inc. | $147.78 | 4 |
| Alnylam Pharmaceuticals Inc. | $82.57 | 3 |
| Kiniksa Pharmaceuticals International, plc | $29.18 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.47 | 1 |
| CVRx Inc. | $9.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.19 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125003712 | CMS |
| Abbott Laboratories | $113.73 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125003714 | CMS |
| Abbott Laboratories | $24.80 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125003716 | CMS |
| ABIOMED | $122.29 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142280217 | CMS |
| ABIOMED | $38.11 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142280233 | CMS |
| Alnylam Pharmaceuticals Inc. | $24.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125842413 | CMS |
| Alnylam Pharmaceuticals Inc. | $24.15 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125842467 | CMS |
| Alnylam Pharmaceuticals Inc. | $33.47 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125842523 | CMS |
| Amgen Inc. | $112.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117519563 | CMS |
| Amgen Inc. | $13.77 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115477390 | CMS |
| Amgen Inc. | $16.21 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115477397 | CMS |
| Amgen Inc. | $4.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115477403 | CMS |
| CVRx, Inc. | $9.19 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127781314 | CMS |
| Kiniksa Pharmaceuticals International, plc | $29.18 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154855587 | CMS |
| Novartis Pharmaceuticals Corporation | $23.47 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086665875 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.